Coeliac disease: in vivo toxicity of the putative immunodominant epitope.
about
Recent advances in coeliac diseaseNon-celiac gluten sensitivity: questions still to be answered despite increasing awarenessAntagonists and non-toxic variants of the dominant wheat gliadin T cell epitope in coeliac diseaseCross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac diseaseA role for tissue transglutaminase in alpha-gliadin peptide cytotoxicityNon-celiac gluten sensitivity: literature reviewParallels between pathogens and gluten peptides in celiac sprueDivergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity.New understanding of gluten sensitivity.The immune recognition of gluten in coeliac disease.Coeliac disease: a diverse clinical syndrome caused by intolerance of wheat, barley and rye.T cells in peripheral blood after gluten challenge in coeliac disease.Translational mini-review series on the immunogenetics of gut disease: immunogenetics of coeliac disease.Coeliac disease: current approach and future prospects.Quantitation of the immunodominant 33-mer peptide from α-gliadin in wheat flours by liquid chromatography tandem mass spectrometryPharmacotherapy and management strategies for coeliac disease.Celiac disease in pediatric patients with autoimmune hepatitis: etiology, diagnosis, and management.Identification of coeliac disease triggering glutenin peptides in adults.Effects of water stress on the composition and immunoreactive properties of gliadins from two wheat cultivars: Nawra and Tonacja.Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A.A novel and sensitive method for the detection of T cell stimulatory epitopes of alpha/beta- and gamma-gliadin.Isolation and characterization of circulating tissue transglutaminase-specific T cells in coeliac disease.
P2860
Q22306523-B4984A2B-6941-4683-8E62-0EF559D6498DQ24567671-EDDC5CA1-37C9-4625-9667-A0BC1659A773Q24680221-3A70B27E-722B-49E5-AB55-ED1CBFA0D941Q24680243-C9F5B658-684E-4FA6-8C4B-C77924D72EE5Q24683342-AC06EBD2-F8E0-4AE2-A81D-3D46603B4905Q28307766-53674279-8884-45AC-ACB2-DBB975E68CCFQ33329537-F6C76AA2-7057-4096-8AA4-52B14E9F3812Q33842864-B115C92D-23C5-47AA-A6E7-3C1C32105877Q34257275-BFE723D1-F39F-4A5E-B034-D3DE4E883755Q34423420-055B6597-3902-412D-86AC-CBAC4F8FB196Q34470900-DD201E3D-2E57-471E-999A-8DC83CC4759EQ35597668-7666C085-AEED-444F-9E84-993A3E66F7DEQ37247193-0EF3D297-3CAD-4985-9171-85393341DB86Q37368419-268CE939-E1FB-48C5-AFBA-7B978C3495E9Q37715025-FD29010B-60D4-4235-A1E8-3CA940E01D90Q37896092-0338E5A7-F692-483C-99B3-DB47DCCF1BC5Q37965669-0F537485-21BE-4C18-B246-D9D3DF01E501Q38791398-059A2FC6-EAA1-4FE9-93B3-3F3346F93F28Q38924502-7EE3CDD5-BCBC-437F-8167-8C60BD86143BQ42482567-48179988-EF2B-4F25-AEB1-F00A96C39154Q43004901-781B6884-A1DC-4298-965C-8F055C24F222Q51059143-751B3046-0AAC-4463-86D4-6553D0C0ADB0
P2860
Coeliac disease: in vivo toxicity of the putative immunodominant epitope.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Coeliac disease: in vivo toxicity of the putative immunodominant epitope.
@en
Coeliac disease: in vivo toxicity of the putative immunodominant epitope.
@nl
type
label
Coeliac disease: in vivo toxicity of the putative immunodominant epitope.
@en
Coeliac disease: in vivo toxicity of the putative immunodominant epitope.
@nl
prefLabel
Coeliac disease: in vivo toxicity of the putative immunodominant epitope.
@en
Coeliac disease: in vivo toxicity of the putative immunodominant epitope.
@nl
P2093
P2860
P356
P1433
P1476
Coeliac disease: in vivo toxicity of the putative immunodominant epitope.
@en
P2093
Ciclitira PJ
Pollock EL
P2860
P304
P356
10.1136/GUT.52.12.1698
P407
P577
2003-12-01T00:00:00Z